Identification and validation of bioactive small molecule target through phenotypic screening

Yoon Sun Cho, Ho Jeong Kwon

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

Original languageEnglish
Pages (from-to)1922-1928
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume20
Issue number6
DOIs
Publication statusPublished - 2012 Mar 15

Fingerprint

Screening
Molecules
Proteins
Electric network analysis
Genomics
Proteomics
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

@article{9dab8f996cd848dcabd11f4a718152b0,
title = "Identification and validation of bioactive small molecule target through phenotypic screening",
abstract = "For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.",
author = "Cho, {Yoon Sun} and Kwon, {Ho Jeong}",
year = "2012",
month = "3",
day = "15",
doi = "10.1016/j.bmc.2011.11.021",
language = "English",
volume = "20",
pages = "1922--1928",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "6",

}

Identification and validation of bioactive small molecule target through phenotypic screening. / Cho, Yoon Sun; Kwon, Ho Jeong.

In: Bioorganic and Medicinal Chemistry, Vol. 20, No. 6, 15.03.2012, p. 1922-1928.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and validation of bioactive small molecule target through phenotypic screening

AU - Cho, Yoon Sun

AU - Kwon, Ho Jeong

PY - 2012/3/15

Y1 - 2012/3/15

N2 - For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

AB - For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

UR - http://www.scopus.com/inward/record.url?scp=84857921370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857921370&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.11.021

DO - 10.1016/j.bmc.2011.11.021

M3 - Article

VL - 20

SP - 1922

EP - 1928

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 6

ER -